Nanomi
Anneke Blom is an experienced professional in the pharmaceutical and biotechnology industries, currently serving as the Head of Research and Development at Nanomi since February 2025. Prior experience includes roles as Director of Chemistry, Manufacturing & Control at Venn Life Sciences from April 2016 to February 2025, and various positions at MSD, Patheon, and OctoPlus, where responsibilities encompassed project management, CMC development, and technology transfer among others. Anneke co-founded CoVaccine B.V., focusing on vaccine adjuvants, and has a solid academic background with degrees in Medical Histology and VWO. Continuous professional development includes various courses in management and the pharmaceutical field.
This person is not in any teams
This person is not in any offices
Nanomi
Nanomi is a leader in the field of microsphere and nanoparticle manufacture and development of long-acting release medicines. The company earned this unique position by focusing not only on high-quality research, but also on the development of a pipeline of products based on its proprietary Microsieve technology, both in-house and in collaborationwith partners.Nanomi has developed a cutting-edge technology - the Microsieve technology - for the development of long-acting release medicines, a technology that offers unprecedented drug development potential for the future.